标题
Conjunctival Melanoma: Current Treatments and Future Options
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-22
DOI
10.1007/s40257-019-00500-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
- (2019) Paul T. Finger et al. Journal for ImmunoTherapy of Cancer
- Global microRNA profiling of metastatic conjunctival melanoma
- (2019) Lauge H. Mikkelsen et al. MELANOMA RESEARCH
- Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
- (2019) Ernesto Rossi et al. Frontiers in Oncology
- Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy
- (2019) Longwen Xu et al. Journal of Translational Medicine
- NF1 mutations in conjunctival melanoma
- (2018) S. L. Scholz et al. BRITISH JOURNAL OF CANCER
- Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF -mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
- (2018) Reinhard Dummer et al. LANCET ONCOLOGY
- Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG‐N0377, Alliance)
- (2018) Jesus Vera Aguilera et al. ONCOLOGIST
- Predominance of triple wild-type and IGF2R mutations in mucosal melanomas
- (2018) Yuuki Iida et al. BMC CANCER
- Immunotherapy With Programmed Cell Death 1 Inhibitors for 5 Patients With Conjunctival Melanoma
- (2018) Oded Sagiv et al. JAMA Ophthalmology
- Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma
- (2017) Xian Chan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The NF1 gene in tumor syndromes and melanoma
- (2017) Maija Kiuru et al. LABORATORY INVESTIGATION
- Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
- (2017) Ursula A. Germann et al. MOLECULAR CANCER THERAPEUTICS
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors
- (2017) Lora R. Dagi Glass et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Dual MEK/AKT inhibition with trametinib and GSK2141795 does not yield clinical benefit in metastatic NRAS-mutant and wild-type melanoma
- (2017) Alain P. Algazi et al. Pigment Cell & Melanoma Research
- Advances in the management of conjunctival melanoma
- (2017) Gargi K. Vora et al. SURVEY OF OPHTHALMOLOGY
- NRAS-mutant melanoma: current challenges and future prospect
- (2017) Eva Muñoz-Couselo et al. OncoTargets and Therapy
- First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study
- (2017) Ryan J. Sullivan et al. Cancer Discovery
- Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
- (2017) Ioana Cosgarea et al. Oncotarget
- Pembrolizumab for Recurrent Conjunctival Melanoma
- (2017) Ashwini Kini et al. JAMA Ophthalmology
- Molecular Characteristics of Conjunctival Melanoma Using Whole-Exome Sequencing
- (2017) Swarup S. Swaminathan et al. JAMA Ophthalmology
- A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
- (2016) A. Maleka et al. BMC CANCER
- Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial
- (2016) Paolo A Ascierto et al. LANCET ONCOLOGY
- UV light signature in conjunctival melanoma; not only skin should be protected from solar radiation
- (2015) Carlo Rivolta et al. JOURNAL OF HUMAN GENETICS
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
- (2015) Michael Krauthammer et al. NATURE GENETICS
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated WithBRAFMutations
- (2015) Ann-Cathrine Larsen et al. JAMA Ophthalmology
- The NF1 gene revisited – from bench to bedside
- (2015) Yoon-Sim Yap et al. Oncotarget
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases
- (2013) A Zebary et al. BRITISH JOURNAL OF CANCER
- Conjunctival Melanomas Harbor BRAF and NRAS Mutations--Response
- (2013) K. G. Griewank et al. CLINICAL CANCER RESEARCH
- Conjunctival Melanomas Harbor BRAF and NRAS Mutations--Letter
- (2013) J. L. Weber et al. CLINICAL CANCER RESEARCH
- Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
- (2013) K. G. Griewank et al. CLINICAL CANCER RESEARCH
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin
- (2013) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma
- (2013) Simon J Furney et al. JOURNAL OF PATHOLOGY
- Ipilimumab for Patients With Advanced Mucosal Melanoma
- (2013) M. A. Postow et al. ONCOLOGIST
- Ipilimumab and Its Toxicities: A Multidisciplinary Approach
- (2013) L. A. Fecher et al. ONCOLOGIST
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Radiotherapy for ocular tumours
- (2012) C Stannard et al. EYE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites
- (2011) K. Omholt et al. CLINICAL CANCER RESEARCH
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboringc-KitMutation or Amplification
- (2011) Jun Guo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- KIT mutations in ocular melanoma: frequency and anatomic distribution
- (2011) Michelle L Wallander et al. MODERN PATHOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Association between MC1R Genotype and BRAF Mutation Status in Cutaneous Melanoma: Findings from an Australian Population
- (2009) Elke Hacker et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- KIT as a Therapeutic Target in Melanoma
- (2009) Maria C. Garrido et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- KIT Gene Mutations and Copy Number in Melanoma Subtypes
- (2008) C. Beadling et al. CLINICAL CANCER RESEARCH
- Ocular melanoma: relatively rare but requiring respect
- (2008) Carol L. Shields et al. CLINICS IN DERMATOLOGY
- An audit of conjunctival melanoma treatment in Liverpool
- (2008) B Damato et al. EYE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started